Editorial: Toxicity mechanism and clinical features of PD-1/PD-l1 inhibitors in treatment of cancer, volume II

Chuqi Lei; Xiangyi Kong; Ryan J. Sullivan; Caisheng Wu; Dawei Wang; Lin Zhang

doi:10.3389/fphar.2023.1136373

Editorial: Toxicity mechanism and clinical features of PD-1/PD-l1 inhibitors in treatment of cancer, volume II

Chuqi Lei, Xiangyi Kong, Ryan J. Sullivan, Caisheng Wu, Dawei Wang, Lin Zhang

Office of the Pro Vice-Chancellor and President (Suzhou)

Research output: Contribution to journal › Editorial › Other › peer-review

Original language	English
Article number	1136373
Number of pages	2
Journal	Frontiers in Pharmacology
Volume	14
DOIs	https://doi.org/10.3389/fphar.2023.1136373
Publication status	Published - 6 Feb 2023

Keywords

cancer
clinical features
immunotherapy
PD-1/PD-L1 inhibitors
toxicity mechanism

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fphar.2023.1136373Licence: CC BY

489093403-oaFinal published version, 523 KBLicence: CC BY

Cite this

@article{45232a8aa87a4b8bbc933f42dad4dc0d,

title = "Editorial: Toxicity mechanism and clinical features of PD-1/PD-l1 inhibitors in treatment of cancer, volume II",

keywords = "cancer, clinical features, immunotherapy, PD-1/PD-L1 inhibitors, toxicity mechanism",

author = "Chuqi Lei and Xiangyi Kong and Sullivan, {Ryan J.} and Caisheng Wu and Dawei Wang and Lin Zhang",

year = "2023",

month = feb,

day = "6",

doi = "10.3389/fphar.2023.1136373",

language = "English",

volume = "14",

journal = "Frontiers in Pharmacology",

issn = "1663-9812",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Editorial: Toxicity mechanism and clinical features of PD-1/PD-l1 inhibitors in treatment of cancer, volume II

AU - Lei, Chuqi

AU - Kong, Xiangyi

AU - Sullivan, Ryan J.

AU - Wu, Caisheng

AU - Wang, Dawei

AU - Zhang, Lin

PY - 2023/2/6

Y1 - 2023/2/6

KW - cancer

KW - clinical features

KW - immunotherapy

KW - PD-1/PD-L1 inhibitors

KW - toxicity mechanism

UR - http://www.scopus.com/inward/record.url?scp=85148522713&partnerID=8YFLogxK

U2 - 10.3389/fphar.2023.1136373

DO - 10.3389/fphar.2023.1136373

M3 - Editorial

C2 - 36814493

AN - SCOPUS:85148522713

SN - 1663-9812

VL - 14

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

M1 - 1136373

ER -

Editorial: Toxicity mechanism and clinical features of PD-1/PD-l1 inhibitors in treatment of cancer, volume II

Keywords

UN SDGs

Access to Document

Other files and links

Cite this